Galit Hirsh‐Yechezkel

Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of a<i>BRCA1</i>or<i>BRCA2</i>Mutation

Baruch Modan, Patricia Hartge, Galit Hirsh‐Yechezkel et al. · New England Journal of Medicine · 2001 · 388 citations · Full text

Effect of <i>BRCA1/2</i> Mutations on Long-Term Survival of Patients With Invasive Ovarian Cancer: The National Israeli Study of Ovarian Cancer

Angela Chetrit, Galit Hirsh‐Yechezkel, Yehuda Ben‐David et al. · Journal of Clinical Oncology · 2007 · 320 citations · Full text

Effect of <i>BRCA</i> Mutations on the Length of Survival in Epithelial Ovarian Tumors

Y. Ben David, Angela Chetrit, Galit Hirsh‐Yechezkel et al. · Journal of Clinical Oncology · 2002 · 126 citations

Blood Samples, Cancer Pathology, Cancer Epidemiology +15

Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer

Walter H. Gotlieb, Angela Chetrit, Joseph Menczer et al. · Gynecologic Oncology · 2005 · 71 citations

Tumoral Pathology, Medicine, Borderline Ovarian Tumors +7

Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israel

Galit Hirsh‐Yechezkel, Angela Chetrit, Flora Lubin et al. · Gynecologic Oncology · 2003 · 65 citations

Somatic Variant, Cancer Epidemiology, Medicine +9